Works matching IS 08876924 AND DT 2005 AND VI 19 AND IP 11

Results: 31

Effects of overexpression of HBP1 upon growth and differentiation of leukemic myeloid cells.

Published in:

Leukemia (08876924), 2005, v. 19, n. 11, p. 1958, doi. 10.1038/sj.leu.2403918

By:

Yao, C. J.;
Works, K.;
Romagnoli, P. A.;
Austin, G. E.

Publication type:

Article

Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients.

Published in:

2005

By:

Piazza, R. G.;
Magistroni, V.;
Andreoni, F.;
Franceschino, A.;
Tornaghi, L.;
Varella-Garcia, M.;
Bungaro, S.;
Colnaghi, F.;
Corneo, G.;
Pogliani, E. M.;
Gambacorti-Passerini, C.

Publication type:

Letter

Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia.

Published in:

2005

By:

Sonoki, T.;
Iwanaga, E.;
Mitsuya, H.;
Asou, N.

Publication type:

Letter

Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 11, p. 1941, doi. 10.1038/sj.leu.2403836

By:

Meng, Y.-S.;
Khoury, H.;
Dick, J. E.;
Minden, M. D.

Publication type:

Article

Gene expression profiling of chronic lymphocytic leukemia can discriminate cases with stable disease and mutated Ig genes from those with progressive disease and unmutated Ig genes.

Published in:

2005

By:

Vasconcelos, Y.;
De Vos, J.;
Vallat, L.;
Rème, T.;
Lalanne, A. I.;
Wanherdrick, K.;
Michel, A.;
Nguyen-Khac, F.;
Oppezzo, P.;
Magnac, C.;
Maloum, K.;
Ajchenbaum-Cymbalista, F.;
Troussard, X.;
Leporrier, M.;
Klein, B.;
Dighiero, G.;
Davi, F.

Publication type:

Letter

The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio.

Published in:

Leukemia (08876924), 2005, v. 19, n. 11, p. 1969, doi. 10.1038/sj.leu.2403890

By:

Terpos, E.;
Mihou, D.;
Szydlo, R.;
Tsimirika, K.;
Karkantaris, C.;
Politou, M.;
Voskaridou, E.;
Rahemtulla, A.;
Dimopoulos, M. A.;
Zervas, K.

Publication type:

Article

CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes.

Published in:

2005

By:

Dik, W. A.;
Brahim, W.;
Braun, C.;
Asnafi, V.;
Dastugue, N.;
Bernard, O. A.;
van Dongen, J. J. M.;
Langerak, A. W.;
Macintyre, E. A.;
Delabesse, E.

Publication type:

journal article

CD33 is expressed on plasma cells of a significant number of myeloma patients, and may represent a therapeutic target.

Published in:

2005

By:

Robillard, N.;
Wuillème, S.;
Lodé, L.;
Magrangeas, F.;
Minvielle, S.;
Avet-Loiseau, H.;
Wuillème, S;
Lodé, L

Publication type:

Letter

Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature.

Published in:

2005

By:

Ferrari, A.;
Luppi, M.;
Potenza, L.;
Riva, G.;
Morselli, M.;
Imovilli, A.;
Volzone, F.;
Rossi, G.;
Codeluppi, M.;
Guaraldi, G.;
Torelli, G.

Publication type:

Letter

Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells.

Published in:

Leukemia (08876924), 2005, v. 19, n. 11, p. 1896, doi. 10.1038/sj.leu.2403949

By:

Chuah, C.;
Barnes, D. J.;
Kwok, M.;
Corbin, A.;
Deininger, M. W. N.;
Druker, B. J.;
Melo, J. V.

Publication type:

Article

Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation.

Published in:

Leukemia (08876924), 2005, v. 19, n. 11, p. 1977, doi. 10.1038/sj.leu.2403929

By:

Zhang, W.;
McQueen, T.;
Schober, W.;
Rassidakis, G.;
Andreeff, M.;
Konopleva, M.

Publication type:

Article

Antigen-specific cellular immunotherapy of leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 11, p. 1863, doi. 10.1038/sj.leu.2403930

By:

van Driessche, A.;
Gao, L.;
Stauss, H. J.;
Ponsaerts, P.;
van Bockstaele, D. R.;
Berneman, Z. N.;
van Tendeloo, V. F. I.

Publication type:

Article

Coexistence of AML1/RUNX1 and BCR-ABL point mutations in an imatinib-resistant form of CML.

Published in:

2005

By:

Corm, S.;
Biggio, V.;
Roche-Lestienne, C.;
Laï, J.-L.;
Yakoub-Agha, I.;
Philippe, N.;
Nicolini, F.-E.;
Facon, T.;
Preudhomme, C.

Publication type:

Letter

Imatinib mesylate suppresses cytokine synthesis by activated CD4 T cells of patients with chronic myelogenous leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 11, p. 1905, doi. 10.1038/sj.leu.2403933

By:

Gao, H.;
Lee, B.-N.;
Talpaz, M.;
Donato, N. J.;
Cortes, J. E.;
Kantarjian, H. M.;
Reuben, J. M.

Publication type:

Article

Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group

Published in:

Leukemia (08876924), 2005, v. 19, n. 11, p. 1929, doi. 10.1038/sj.leu.2403934

By:

Zwierzina, H.;
Suciu, S.;
Loeffler-Ragg, J.;
Neuwirtova, R.;
Fenaux, P.;
Beksac, M.;
Harousseau, J.;
Nuessler, V.;
Cermak, J.;
Solbu, G.;
Willemze, R.;
de Witte, T.;
Amadori, S.

Publication type:

Article

A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinib.

Published in:

Leukemia (08876924), 2005, v. 19, n. 11, p. 1859, doi. 10.1038/sj.leu.2403935

By:

Crossman, L. C.;
O'Hare, T.;
Lange, T.;
Willis, S. G.;
Stoffregen, E. P.;
Corbin, A. S.;
O'Brien, S. G.;
Heinrich, M. C.;
Druker, B. J.;
Middleton, P. G.;
Deininger, M. W. N.

Publication type:

Article

Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab.

Published in:

2005

By:

Bruns, I.;
Fox, F.;
Reinecke, P.;
Kobbe, G.;
Kronenwett, R.;
Jung, G.;
Haas, R.

Publication type:

Letter

Efficient and easy detection of MLL-AF4, MLL-AF9 and MLL-ENL fusion gene transcripts by multiplex real-time quantitative RT-PCR in TaqMan and LightCycler.

Published in:

2005

By:

Jansen, M. W. J. C.;
van der Velden, V. H. J.;
van Dongen, J. J. M.

Publication type:

Letter

Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706.

Published in:

Leukemia (08876924), 2005, v. 19, n. 11, p. 1880, doi. 10.1038/sj.leu.2403940

By:

Hussein, M. A.;
Gundacker, H.;
Head, D. R.;
Elias, L.;
Foon, K. A.;
Boldt, D. H.;
Dobin, S. M.;
Dakhil, S. R.;
Budd, G. T.;
Appelbaum, F. R.

Publication type:

Article

MDM2 promoter variation and age of diagnosis of acute lymphoblastic leukemia.

Published in:

2005

By:

Swinney, R. M.;
Hsu, S. C.;
Hirschman, B. A.;
Chen, T. T.-C.;
Tomlinson, G. E.

Publication type:

Letter

A microRNA cluster as a target of genomic amplification in malignant lymphoma.

Published in:

2005

By:

Tagawa, H.;
Seto, M.

Publication type:

Letter

Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 11, p. 1887, doi. 10.1038/sj.leu.2403943

By:

Meier, M.;
den Boer, M. L.;
Hall, A. G.;
Irving, J. A. E.;
Passier, M.;
Minto, L.;
van Wering, E. R.;
Janka-Schaub, G. E.;
Pieters, R.

Publication type:

Article

Risk factors of myelodysplastic syndromes: a case–control study.

Published in:

Leukemia (08876924), 2005, v. 19, n. 11, p. 1912, doi. 10.1038/sj.leu.2403945

By:

Strom, S. S.;
Gu, Y.;
Gruschkus, S. K.;
Pierce, S. A.;
Estey, E. H.

Publication type:

Article

Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients.

Published in:

2005

By:

Rund, D.;
Krichevsky, S.;
Bar-Cohen, S.;
Goldschmidt, N.;
Kedmi, M.;
Malik, E.;
Gural, A.;
Shafran-Tikva, S.;
Ben-Neriah, S.;
Ben-Yehuda, D.

Publication type:

journal article

Dual tyrosine kinase inhibitors in chronic myeloid leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 11, p. 1872, doi. 10.1038/sj.leu.2403950

By:

Martinelli, G.;
Soverini, S.;
Rosti, G.;
Baccarani, M.

Publication type:

Article

Transfection of antisense core 2 β1,6-N-acetylglucosaminyltransferase-1 cDNA suppresses selectin ligand expression and tissue infiltration of B-cell precursor leukemia cells.

Published in:

Leukemia (08876924), 2005, v. 19, n. 11, p. 1934, doi. 10.1038/sj.leu.2403951

By:

Kikuchi, J.;
Ozaki, H.;
Nonomura, C.;
Shinohara, H.;
Iguchi, S.;
Nojiri, H.;
Hamada, H.;
Kiuchi, A.;
Nakamura, M.

Publication type:

Article

Prognostic impact of vascular density and fibrosis in the bone marrow of children with high-risk acute lymphoblastic leukemia.

Published in:

2005

By:

Norén-Nyström, U.;
Roos, G.;
Bergh, A.;
Forestier, E.

Publication type:

Letter

Remission of pure red cell aplasia in T-cell receptor γδ-large granular lymphocyte leukemia after therapy with low-dose alemtuzumab.

Published in:

2005

By:

Schützinger, C.;
Gaiger, A.;
Thalhammer, R.;
Vesely, M.;
Fritsche-Polanz, R.;
Schwarzinger, I.;
Öhler, L.;
Simonitsch-Klupp, I.;
Reinhard, F.;
Jäger, U.

Publication type:

Letter

Quantification of CBFB-MYH11 fusion gene levels in paired peripheral blood and bone marrow samples by real-time PCR.

Published in:

2005

By:

Boeckx, N.;
De Roover, J.;
van der Velden, V. H. J.;
Maertens, J.;
Uyttebroeck, A.;
van den Berghe, P.;
van Dongen, J. J. M.

Publication type:

Letter

Deletion of the inositide-specific phospholipase c β1 gene is a rare event in myelodysplastic syndrome and thus of limited value to predict leukemic progression.

Published in:

2005

By:

Verburgh, E.;
Verhoef, G.;
van den Berghe, P.;
Hagemeijer, A.

Publication type:

Letter

Abl inhibitor BMS354825 binding mode in Ableson kinase revealed by molecular docking studies.

Published in:

2005

By:

Gambacorti-Passerini, C.;
Gasser, M.;
Ahmed, S.;
Scapozza, L.

Publication type:

Correction Notice